Frontiers in Pharmacology (Sep 2022)

Corrigendum: Honokiol ameliorates post-myocardial infarction heart failure through Ucp3-mediated reactive oxygen species inhibition

  • Jianyu Liu,
  • Minghai Tang,
  • Tao Li,
  • Zhengying Su,
  • Zejiang Zhu,
  • Caixia Dou,
  • Yan Liu,
  • Heying Pei,
  • Jianhong Yang,
  • Haoyu Ye,
  • Lijuan Chen

DOI
https://doi.org/10.3389/fphar.2022.1000887
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords